Biotech firm Galapagos-owned drug discovery company Argenta has signed a collaboration agreement with Denmark-based biotech Pcovery for the development of anti-fungal agents.

Pcovery, founded in 2009, was spun out of Aarhus and Copenhagen universities’ collaboration the Centre for Membrane Pumps in Cells and Disease, otherwise known as the PUMPkin Centre. The biotech focuses on the development of a broad spectrum of anti-fungal agents which target membrane proteins.

The collaboration with Argenta will be funded by a Seeding Drug Discovery award…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?